John E. Leikauf

Area of research

Psychiatry and Mental health · Cognitive Neuroscience

Research interest

Research interests include Atomoxetine, Psychology, Cognition, Randomized controlled trial, Action (physics), and Stimulant.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial

Journal of Psychiatric Research 2018cited by 28position: middledoi

A Signature of Attention-Elicited Electrocortical Activity Distinguishes Response From Non-Response to the Non-Stimulant Atomoxetine in Children and Adolescents With ADHD

Journal of Attention Disorders 2017cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kristi R. Griffiths · University of Technology Sydney2 papers (2017–2018)Tracey W. Tsang · The University of Sydney2 papers (2017–2018)Leanne M. Williams · Stanford University2 papers (2017–2018)Michael Kohn · The University of Sydney2 papers (2017–2018)Daniel F. Hermens · University of the Sunshine Coast1 papers (2018–2018)— · 1 papers (2018–2018)Erdahl Teber · Concord Repatriation General Hospital1 papers (2017–2017)Simon D. Clarke · Westmead Hospital1 papers (2017–2017)Donna M. Palmer · Data611 papers (2017–2017)— · 1 papers (2017–2017)